How to Value a Medical Practice Startup

Most conversations I have with physicians about selling a startup practice end with me telling them something they don't want to hear: the practice probably isn't worth what they think, and the best exit available to them is likely not a sale at all. It's becoming a hospital employee.

That's not pessimism. It's the economic reality of how medical practices under three years old actually get valued in 2026. The Stark Law, anti-kickback regulations, and fair market value requirements combine to create a narrow valuation corridor that feels unfair to founders who just poured two years and $400K into building something. Here's how to think about it clearly.

Why Medical Practices Are Different

Dental and veterinary practices have robust private-buyer markets because the regulatory environment is relatively clean. A dentist can sell their practice to another dentist with minimal legal friction, and the price can be whatever the two parties agree to.

Physician practice sales operate under a very different regime. Any time a hospital, health system, or physician-owned entity that makes referrals acquires a practice, the purchase price has to be independently supported as fair market value under Stark Law and the Anti-Kickback Statute. That means a third-party valuation firm — Pinnacle, VMG, HealthCare Appraisers, or similar — has to sign off on the number. And those firms are conservative for a reason: bad fair market value opinions have ended careers and generated seven-figure false claims settlements.

The practical effect is that a medical practice sale isn't a free negotiation. It's a negotiation inside a box defined by what a valuation firm will defensibly sign off on. For an established multi-physician group with real earnings, the box is reasonably generous. For a startup practice, the box is tiny.

The Three Valuation Methods and Why Only One Applies

Healthcare valuation firms use three standard approaches: the asset approach, the income approach (typically a discounted cash flow), and the market approach (comparable transactions). For an established practice, all three get weighted and reconciled. For a startup, only the asset approach usually produces a defensible number.

The market approach fails because there are essentially no public comparables for startup medical practices. Physician practice transactions that do get reported are almost all established groups with multi-year EBITDA histories. A valuation firm can't anchor a defensible opinion to comparables that don't exist.

The income approach usually fails because a DCF on a startup practice requires projecting cash flows that have no historical basis. Valuation firms are deeply skeptical of hockey-stick projections from founders. When they do run a DCF on a startup, they build in huge discount rates (18-25%) and aggressive haircuts on projected revenue, which usually produces a number below the asset value anyway.

That leaves the asset approach, which values the practice as the sum of its tangible assets — equipment, leasehold improvements, medical supplies — plus a modest intangible component for things like the phone number, website, and medical records. For a startup that spent $425K on buildout and equipment, a defensible asset-based valuation typically lands at $180K-$275K eighteen months in. The rest has depreciated away or was never recoverable.

When DCF Actually Makes Sense

There's one scenario where an income approach on a startup practice produces a number that beats asset value: when the practice has a clear, contractual, documented revenue stream that can be projected with confidence.

This usually means capitated contracts with Medicare Advantage plans, managed care risk arrangements, or value-based care contracts with measurable PMPM revenue. A primary care practice 18 months old with 1,800 attributed Medicare Advantage lives under a shared-risk contract has a cash flow story a valuation firm can actually model. The same practice with no risk contracts and pure fee-for-service billing does not.

If you're in the value-based care lane, your startup practice may support a DCF-derived valuation of 3-6x trailing EBITDA or $500-$1,500 per attributed life, depending on the contract structure. These numbers don't apply to traditional fee-for-service practices.

Hospital Employment as an Exit Alternative

Here's the conversation I have with most physician founders: instead of trying to sell a startup practice for $250K, consider becoming a hospital employee in the same specialty. The economics are usually dramatically better.

A typical hospital employment package for a mid-career specialist includes a signing bonus of $50K-$250K, a guaranteed base salary of $280K-$650K depending on specialty, productivity bonuses, full benefits, malpractice coverage, and practice acquisition payments if the hospital acquires your practice assets. That last piece is often the key: the hospital pays fair market value for your equipment and intangibles (usually in the same $180K-$275K range a private buyer would pay), but the real value is the employment contract that comes with it.

The math works like this: a startup practice generating $60K in owner take-home at month 18 versus a hospital employment offer at $420K base plus $150K in acquisition payments for your assets. You're giving up ownership upside you probably weren't going to realize anyway, in exchange for a stable income and the ability to actually practice medicine without running a small business.

The tradeoffs are real. You lose autonomy. You work on someone else's schedule and RVU targets. You may have to refer within the hospital's network. Some physicians genuinely hate this and prefer to grind through the startup ramp. Others find it liberating. Just understand it's usually the highest-value exit available.

Private Sale to Another Physician

The other realistic exit is a private sale to another physician in your specialty, either someone fresh out of fellowship looking to skip the startup phase or an established physician looking to expand. These deals don't require a hospital-grade fair market value opinion because no referral source is involved, so there's more negotiating flexibility.

Private physician-to-physician deals for startup practices typically price at asset value plus a small goodwill premium, often landing at $250K-$500K for a practice with modest traction. The buyer usually takes over the lease, assumes some of the equipment debt, and pays a modest cash component for the intangible value. It's not a wealth-creation exit, but it's cleaner than winding the practice down.

If you want to understand how these valuation methods compare across other specialties, my industry multiples guide shows where stabilized medical practices trade — the numbers startups eventually grow into if they survive the ramp.

The Honest Advice for Physician Founders

If you're two years into a startup practice and wondering what it's worth, the honest answer is: probably your depreciated asset value plus a small premium, unless you have value-based care contracts that can support a DCF story. That's $200K-$400K in most cases — well below what you've invested in sweat equity and capital.

The strategic question is almost never "how do I maximize the sale price?" It's "what's the best path forward from here?" For many physicians, that path is hospital employment with a practice acquisition component, not a traditional sale. For others, it's pushing through to Year 4-5 when the practice stabilizes and real valuation methods become available.

What it almost never is: a headline-grabbing exit in Year 2. That's not how medical practice economics work, and any advisor promising otherwise is setting you up for disappointment.